Skip to main content

Table 4 Treatments received over course of therapy for celiac-associated arthritis

From: Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study

Treatment

n (%)

Time to start in months*,

median (IQR)

GF diet

13 (100)

7 (1–17)

Intra-articular corticosteroid injections

10 (76.9)

0 (0–1)

DMARD

Methotrexate

Hydroxychloroquine

Sulfasalazine

10 (76.9)

10 (100)

1 (10.0)

1 (10.0)

8 (2–19)

8 (2–19)

11 (n/a)

47 (n/a)

Biologic

Adalimumab

Etanercept

Tocilizumab

Secukinumab

Rituximab

7 (53.8)

6 (85.7)

2 (28.6)

1 (14.3)

1 (14.3)

1 (14.3)

13 (1-138)

9.5 (5–27)

69.5 (1-138)

38 (n/a)

9 (n/a)

36 (n/a)

  1. Legend. * Time to start treatment, index visit = time 0.